295 related articles for article (PubMed ID: 29332161)
1. The computed tomography adrenal wash-out analysis properly classifies cortisol secreting adrenocortical adenomas.
Humbert AL; Lecoanet G; Moog S; Bouderraoui F; Bresler L; Vignaud JM; Chevalier E; Brunaud L; Klein M; Cuny T
Endocrine; 2018 Mar; 59(3):529-537. PubMed ID: 29332161
[TBL] [Abstract][Full Text] [Related]
2. The 10 Hounsfield units unenhanced computed tomography attenuation threshold does not apply to cortisol secreting adrenocortical adenomas.
Chambre C; McMurray E; Baudry C; Lataud M; Guignat L; Gaujoux S; Lahlou N; Guibourdenche J; Tissier F; Sibony M; Dousset B; Bertagna X; Bertherat J; Legmann P; Groussin L
Eur J Endocrinol; 2015 Sep; 173(3):325-32. PubMed ID: 26243637
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of benign adrenocortical adenomas with 18F-FDG PET accumulation.
Ishiwata K; Suzuki S; Igarashi K; Ruike Y; Naito K; Ishida A; Deguchi-Horiuchi H; Fujimoto M; Koide H; Imamura Y; Sakamoto S; Ichikawa T; Ikeda JI; Yokote K
Eur J Endocrinol; 2021 Jun; 185(1):155-165. PubMed ID: 33960957
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET for the identification of adrenocortical carcinomas among indeterminate adrenal tumors at computed tomography scanning.
Nunes ML; Rault A; Teynie J; Valli N; Guyot M; Gaye D; Belleannee G; Tabarin A
World J Surg; 2010 Jul; 34(7):1506-10. PubMed ID: 20396886
[TBL] [Abstract][Full Text] [Related]
5. Uptake of 18F-FDG in Adrenal Adenomas Is Associated With Unenhanced CT Value and Constituent Cells.
Murayama R; Nishie A; Hida T; Baba S; Inokuchi J; Oda Y; Honda H
Clin Nucl Med; 2019 Dec; 44(12):943-948. PubMed ID: 31490313
[TBL] [Abstract][Full Text] [Related]
6. Adrenocortical tumours: high CT attenuation value correlates with eosinophilia but does not discriminate lipid-poor adenomas from malignancy.
Pennanen M; Raade M; Louhimo J; Sane T; Heiskanen I; Arola J; Haglund C
J Clin Pathol; 2013 Dec; 66(12):1076-80. PubMed ID: 23908452
[TBL] [Abstract][Full Text] [Related]
7. Characterization of adrenocortical tumors by
Paladino NC; Guérin C; Lowery A; Attard A; Essamet W; Slotema E; Morange I; Castinetti F; Brue T; Loundou A; Taïeb D; Sebag F
Surg Oncol; 2018 Jun; 27(2):231-235. PubMed ID: 29937176
[TBL] [Abstract][Full Text] [Related]
8. Computed tomography criteria for discrimination of adrenal adenomas and adrenocortical carcinomas: analysis of the German ACC registry.
Petersenn S; Richter PA; Broemel T; Ritter CO; Deutschbein T; Beil FU; Allolio B; Fassnacht M;
Eur J Endocrinol; 2015 Apr; 172(4):415-22. PubMed ID: 25599706
[TBL] [Abstract][Full Text] [Related]
9. High [18F] 2-fluoro-2-deoxy-D-glucose (FDG) uptake of adrenocortical adenoma showing subclinical Cushing's syndrome.
Shimizu A; Oriuchi N; Tsushima Y; Higuchi T; Aoki J; Endo K
Ann Nucl Med; 2003 Jul; 17(5):403-6. PubMed ID: 12971640
[TBL] [Abstract][Full Text] [Related]
10. 18F-fluorodeoxyglucose positron emission tomography as a diagnostic tool for malignancy of adrenocortical tumours? Preliminary results in 13 consecutive patients.
Tenenbaum F; Groussin L; Foehrenbach H; Tissier F; Gouya H; Bertherat J; Dousset B; Legmann P; Richard B; Bertagna X
Eur J Endocrinol; 2004 Jun; 150(6):789-92. PubMed ID: 15191348
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic features and expression of epidermal growth factor receptor and vascular endothelial growth factor in adrenocortical tumors].
Wang CP; Zhang J; Gao J; Liu PP; Wu SF; Zeng X; Liang ZY
Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):686-90. PubMed ID: 23302311
[TBL] [Abstract][Full Text] [Related]
12. Functioning metastasis from adrenocortical carcinoma.
Cunha C; Donato S; Silva T; Leite V
BMJ Case Rep; 2022 Jan; 15(1):. PubMed ID: 35078872
[TBL] [Abstract][Full Text] [Related]
13. Preoperative 18F-FDG uptake is strongly correlated with malignancy, Weiss score, and molecular markers of aggressiveness in adrenal cortical tumors.
Gust L; Taieb D; Beliard A; Barlier A; Morange I; de Micco C; Henry JF; Sebag F
World J Surg; 2012 Jun; 36(6):1406-10. PubMed ID: 22131094
[TBL] [Abstract][Full Text] [Related]
14. Identification of a clinically homogenous subgroup of benign cortisol-secreting adrenocortical tumors characterized by alterations of the protein kinase A (PKA) subunits and high PKA activity.
Vincent-Dejean C; Cazabat L; Groussin L; Perlemoine K; Fumey G; Tissier F; Bertagna X; Bertherat J
Eur J Endocrinol; 2008 Jun; 158(6):829-39. PubMed ID: 18505904
[TBL] [Abstract][Full Text] [Related]
15. Cushing's syndrome due to bilateral adrenocortical adenomas with unique histological features.
Nomura K; Saito H; Aiba M; Iihara M; Obara T; Takano K
Endocr J; 2003 Apr; 50(2):155-62. PubMed ID: 12803235
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma.
Ardito A; Massaglia C; Pelosi E; Zaggia B; Basile V; Brambilla R; Vigna-Taglianti F; Duregon E; Arena V; Perotti P; Penna D; Terzolo M
Eur J Endocrinol; 2015 Dec; 173(6):749-56. PubMed ID: 26346137
[TBL] [Abstract][Full Text] [Related]
17. Relationship between clear cell/compact cell ratio and computed tomographic attenuation number in adrenocortical adenoma.
Ichiyanagi O; Sasagawa I; Izumi T; Ohji H; Suzuki H; Nakada T; Sugai Y; Yamaguchi K
Int Urol Nephrol; 1999; 31(5):585-90. PubMed ID: 10755348
[TBL] [Abstract][Full Text] [Related]
18. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.
Szolar DH; Korobkin M; Reittner P; Berghold A; Bauernhofer T; Trummer H; Schoellnast H; Preidler KW; Samonigg H
Radiology; 2005 Feb; 234(2):479-85. PubMed ID: 15671003
[TBL] [Abstract][Full Text] [Related]
19. Cortisol-Producing Adrenal Adenomas With Intense Activity on 68Ga-Pentixafor PET/CT.
Ding J; Tong A; Zhang Y; Zhang H; Huo L
Clin Nucl Med; 2021 Apr; 46(4):350-352. PubMed ID: 33492858
[TBL] [Abstract][Full Text] [Related]
20. Radiologically defined lipid-poor adrenal adenomas: histopathological characteristics.
De Leo A; Mosconi C; Zavatta G; Tucci L; Nanni C; Selva S; Balacchi C; Ceccarelli C; Santini D; Pantaleo MA; Minni F; Fanti S; Golfieri R; Pagotto U; Vicennati V; Di Dalmazi G
J Endocrinol Invest; 2020 Sep; 43(9):1197-1204. PubMed ID: 32062826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
